Skip to content

Evaluation of Pharmacists-Participated Medication Reconciliation in County Hospitals in China

Evaluation of Pharmacists-Participated Medication Reconciliation in County Hospitals in China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045668
Enrollment
Unknown
Registered
2021-04-20
Start date
2021-09-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic disease

Interventions

intervention group:medication reconciliation
Control group:Conventional treatment

Sponsors

Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences, Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 60 years; 2. The following diseases are covered in the discharge diagnosis: hypertension, hyperlipidemia, diabetes, coronary artery disease (coronary atherosclerotic heart disease; acute myocardial ischemia; angina pectoris; coronary artery stenosis; coronary arteritis; acute myocardium Infarction; Acute Coronary Syndrome), Pulmonary Heart Disease, Atrial Fibrillation, Heart Failure, Chronic Obstructive Pulmonary Disease, Bronchial Asthma; 3. Discharge with >=3 kinds of medicines.

Exclusion criteria

Exclusion criteria: 1. Suffering from malignant tumor, receiving transplant or suffering from other serious complications; 2. Cannot communicate in Chinese; 3. Refuse to accept medication reformation.

Design outcomes

Primary

MeasureTime frame
medication discrepancy;

Countries

China

Contacts

Public ContactGuan Xiaodong

Peking University

guanxiaodong@pku.edu.cn+86 13911232199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026